Terms: = Breast cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Staging
8 results:
1. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer.
Travelli C; Colombo G; Aliotta M; Fagiani F; Fava N; De Sanctis R; Grolla AA; Garcia JGN; Clemente N; Portararo P; Costanza M; Condorelli F; Colombo MP; Sangaletti S; Genazzani AA
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37880182
[TBL] [Abstract] [Full Text] [Related]
2. Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review.
Miglietta F; Fabi A; Generali D; Dieci MV; Arpino G; Bianchini G; Cinieri S; Conte PF; Curigliano G; De Laurentis M; Del Mastro L; De Placido S; Gennari A; Puglisi F; Zambelli A; Perrone F; Guarneri V
Cancer Treat Rev; 2023 Mar; 114():102511. PubMed ID: 36638600
[TBL] [Abstract] [Full Text] [Related]
3. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
O'Brien M; Paz-Ares L; Marreaud S; Dafni U; Oselin K; Havel L; Esteban E; Isla D; Martinez-Marti A; Faehling M; Tsuboi M; Lee JS; Nakagawa K; Yang J; Samkari A; Keller SM; Mauer M; Jha N; Stahel R; Besse B; Peters S;
Lancet Oncol; 2022 Oct; 23(10):1274-1286. PubMed ID: 36108662
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
[TBL] [Abstract] [Full Text] [Related]
5. Locally advanced breast cancer.
Aebi S; Karlsson P; Wapnir IL
Breast; 2022 Mar; 62 Suppl 1(Suppl 1):S58-S62. PubMed ID: 34930650
[TBL] [Abstract] [Full Text] [Related]
6. Malignant pleural mesothelioma: recent developments.
Sinn K; Mosleh B; Hoda MA
Curr Opin Oncol; 2021 Jan; 33(1):80-86. PubMed ID: 33186182
[TBL] [Abstract] [Full Text] [Related]
7. Identification of programmed death ligand-1 positive exosomes in breast cancer based on DNA amplification-responsive metal-organic frameworks.
Cao Y; Wang Y; Yu X; Jiang X; Li G; Zhao J
Biosens Bioelectron; 2020 Oct; 166():112452. PubMed ID: 32738648
[TBL] [Abstract] [Full Text] [Related]
8. Programmed death 1 Ligand 1 expression in breast cancer and its association with patients' clinical parameters.
Li F; Ren Y; Wang Z
J Cancer Res Ther; 2018 Jan; 14(1):150-154. PubMed ID: 29516978
[TBL] [Abstract] [Full Text] [Related]
